Oppenheimer Downgrades Enanta Pharmaceuticals (ENTA) to Perform

August 8, 2018 5:01 AM

Oppenheimer downgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found